应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VHT Vanguard Health Care ETF
盘前交易 05-19 05:25:37 EDT
271.42
+0.80
+0.30%
最高
272.05
最低
269.27
成交量
13.11万
今开
270.01
昨收
270.62
日振幅
1.03%
总市值
160.76亿
流通市值
160.76亿
总股本
5,923万
成交额
3,549万
换手率
0.22%
流通股本
5,923万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
中信证券医疗健康2025年报及2026年一季报总结:创新板块业绩集中兑现 内外共振推动行业质变开始
智通财经 · 05-11
中信证券医疗健康2025年报及2026年一季报总结:创新板块业绩集中兑现 内外共振推动行业质变开始
新股消息 | 从招股书看好医生云医疗:AI驱动的医疗健康科技平台轮廓初现
智通财经 · 05-06
新股消息 | 从招股书看好医生云医疗:AI驱动的医疗健康科技平台轮廓初现
5月医疗保健股多空榜:Sensei及KalVista空头比例居前
环球市场播报 · 05-05
5月医疗保健股多空榜:Sensei及KalVista空头比例居前
前高盛合伙人李逸斌出任摩根大通(JPM.US)全球医疗保健投行业务联席主管
智通财经 · 04-24
前高盛合伙人李逸斌出任摩根大通(JPM.US)全球医疗保健投行业务联席主管
葛兰旗下中欧医疗健康混合一季报:药明康德(603259.SH)位列第一大重仓股 二季度看好创新产业链
智通财经 · 04-22
葛兰旗下中欧医疗健康混合一季报:药明康德(603259.SH)位列第一大重仓股 二季度看好创新产业链
中信证券:药价形成机制迎来大调整 医疗健康产业政策改革进入密集期
智通财经 · 04-17
中信证券:药价形成机制迎来大调整 医疗健康产业政策改革进入密集期
葛兰旗下中欧医疗健康基金年报来袭!重仓股持续聚焦创新药产业链
智通财经 · 04-01
葛兰旗下中欧医疗健康基金年报来袭!重仓股持续聚焦创新药产业链
险企春招忙 AI和医疗健康类人才需求增长
证券日报 · 03-28
险企春招忙 AI和医疗健康类人才需求增长
广州:拓展智能机器人在工业制造、家庭服务、医疗健康等领域的应用
市场资讯 · 03-26
广州:拓展智能机器人在工业制造、家庭服务、医疗健康等领域的应用
印孚瑟斯拟收购两家美国咨询公司,以加强医疗保健和保险技术产品组合
格隆汇 · 03-26
印孚瑟斯拟收购两家美国咨询公司,以加强医疗保健和保险技术产品组合
加载更多
公司概况
公司名称:
Vanguard Health Care ETF
所属市场:
ARCA
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"VHT","market":"US","secType":"STK","nameCN":"Vanguard Health Care ETF","latestPrice":271.42,"timestamp":1779134400000,"preClose":270.62,"halted":0,"volume":131062,"delay":0,"changeRate":0.0029561747099253986,"floatShares":59227656,"shares":59227656,"eps":9.211173,"marketStatus":"盘前交易","change":0.8,"latestTime":"05-19 05:25:37 EDT","open":270.01,"high":272.05,"low":269.27,"amount":35488151.84374,"amplitude":0.010273,"askPrice":299.61,"askSize":40,"bidPrice":268,"bidSize":13,"shortable":3,"etf":1,"ttmEps":9.211173,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779197400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":271.42,"sharesOutstanding":59747167,"nav":270.72,"aum":16048639491.84,"dividendRate":0.0173,"bidAskSpread":0.000475,"postHourTrading":{"tag":"盘后","latestPrice":271.42,"preClose":271.42,"latestTime":"19:40 EDT","volume":94,"amount":25603.41,"timestamp":1779147643570,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5879550459886239,"impliedVol":0.12,"impliedVolPercentile":0.108},"requestUrl":"/m/hq/s/VHT","defaultTab":"news","newsList":[{"id":"2634427222","title":"中信证券医疗健康2025年报及2026年一季报总结:创新板块业绩集中兑现 内外共振推动行业质变开始","url":"https://stock-news.laohu8.com/highlight/detail?id=2634427222","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634427222?lang=zh_cn&edition=full","pubTime":"2026-05-11 08:38","pubTimestamp":1778459891,"startTime":"0","endTime":"0","summary":"2025年板块收入及扣非归母净利润增速分别为+2.77%、+5.76%;2026Q1板块营业收入及扣非归母净利润增速分别为+4.74%、+5.10%。头部Pharma业务结构从传统制药向创新药转变迅速,创新药放量逐步成为营收增长的核心驱动力。2025年Pharma板块的研发费用率为13.47%,相比2024年提升4.55个百分点;2026Q1,板块的研发费用率为13.03%,相比于2025Q1提升4.11个百分点。2025年板块收入增速约27.8%,继续保持较快增长趋势。创新药出海:中国创新药全球价值不断验证,料2026年进入密集数据催化期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","LU1580142542.USD","LU2495084118.USD","BK4585","600030","VHT","BK0196","LU1794554557.SGD","BK1521","LU0405327148.USD","LU2148510915.USD","06030","LU1064130708.USD","LU1655091616.SGD","LU1997245094.SGD","BK0276","BK0188","LU0405327494.USD","LU2289578879.USD","BK1147","LU1064131003.USD","LU1720050803.USD","BK1516","BK1564","LU1997245177.USD","159760","XBI","BK0183","BK4581","BK0028","BK4588","LU1255011170.USD","XLV","BK4550","LU1328615791.USD","IXJ","LABU","LU1997244956.HKD","LU1781817850.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633170905","title":"新股消息 | 从招股书看好医生云医疗:AI驱动的医疗健康科技平台轮廓初现","url":"https://stock-news.laohu8.com/highlight/detail?id=2633170905","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633170905?lang=zh_cn&edition=full","pubTime":"2026-05-06 13:45","pubTimestamp":1778046321,"startTime":"0","endTime":"0","summary":"不过,招股书并未单独披露AI业务收入规模。从招股书来看,好医生云医疗的平台边界,已经从早期的线上服务,延伸到多个基层医疗关键环节。从招股书可以确认,AI好医生诊疗支持系统截至2026年4月6日已覆盖:29个省235个城市520多个县区,触达8500多家基层医疗机构,服务基层医生超过2.4万人,门诊数量超过3200万人次,生成病历超过2800万份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","159760","AIPO","IXJ","VHT","BK4581","ARTY","BK4585","LABU","XBI","AGIX","XLV","BK4550","159891","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633229968","title":"5月医疗保健股多空榜:Sensei及KalVista空头比例居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2633229968","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633229968?lang=zh_cn&edition=full","pubTime":"2026-05-05 03:24","pubTimestamp":1777922640,"startTime":"0","endTime":"0","summary":"随着4月结束,市值20亿美元以下的小型医疗保健股空头头寸显著增加,显示市场对这类高波动性股票的看空情绪升温。 根据最新数据,5月初医疗保健板块空头比例最高的个股包括Sensei Biotherapeutics、KalVista Pharmaceuticals和GlucoTrack。 在空头比例较低的个股中,Beyond Air和Polaryx Therapeutics名列前茅。 值得注意的是,表格中提及的Sensei Biotherapeutics和KalVista Pharmaceuticals均在搜索报告的5月3日数据中列为高位空头标的。投资者需警惕这类高做空比例股票可能面临的逼空风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-05/doc-inhwunrr3304552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","BK4550","BK4585","VHT","BK4588","XBI","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629890197","title":"前高盛合伙人李逸斌出任摩根大通(JPM.US)全球医疗保健投行业务联席主管","url":"https://stock-news.laohu8.com/highlight/detail?id=2629890197","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629890197?lang=zh_cn&edition=full","pubTime":"2026-04-24 14:45","pubTimestamp":1777013116,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据媒体报道,摩根大通 任命Jerry Lee李逸斌、Nick Richitt为全球医疗保健投资银行联席主管。Jerry Lee,刚于今年第一季度加入摩根大通,此前他在高盛工作逾19年,他于2020年便晋升为高盛合伙人,离开高盛前担任全球生物医药投行业务和医疗保健投行业务主管,职业生涯中已为逾3000亿美元的已宣布并购交易提供过咨询。Jerry Lee,1999年获耶鲁大学学士学位、2007年获宾夕法尼亚大学沃顿商学院MBA学位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0345770993.USD","LU2746668461.USD","LU1868836914.USD","IE0034235295.USD","JPMO","LU0859254822.USD","LU0976567544.SGD","LU1548497426.USD","LU2237438978.USD","LU0215105999.USD","BK4127","LU1551013425.SGD","BK4533","LU2430703178.SGD","LU2054465674.USD","VHT","LU0203345920.USD","LU1720051017.SGD","BK4207","LU0265550359.USD","LU2756315318.SGD","XBI","LU2552382132.HKD","LU0256863811.USD","LU2023250504.SGD","JPO","IE00BDRTCR15.USD","LU1267930490.SGD","LU2237443549.SGD","LU0310799852.SGD","LU2237443622.USD","LU1868836757.USD","IE00BDCRKT87.USD","BK4534","IE00BN8TJ469.HKD","LU1145028129.USD","LU1366192091.USD","XLV","LU0345769631.USD","LU0203347892.USD","LU1917777945.USD","GSX","LU0640476718.USD","LU2592432038.USD","BK4504","LU1363072403.SGD","LU1064131342.USD","LU0061475181.USD","LABU","LU2750360997.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629930310","title":"葛兰旗下中欧医疗健康混合一季报:药明康德(603259.SH)位列第一大重仓股 二季度看好创新产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2629930310","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629930310?lang=zh_cn&edition=full","pubTime":"2026-04-22 10:52","pubTimestamp":1776826345,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,4月22日,中欧基金披露葛兰和赵磊共同管理的中欧医疗健康混合型证券投资基金2026年第1季度报告。葛兰表示,一季度基于长期价值投资思路,继续重点关注创新药械及其产业链、消费医疗等领域。调仓换股方面,与2025年第4季度相比,中欧医疗健康混合在一季度减仓了康龙化成、泰格医药等个股,增持了凯莱英、信立泰、海思科、科伦药业,而艾力斯新进持仓前十。创新药及产业链预计将延续高景气度,是二季度重点关注方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLV","BK4550","159760","LU2488822045.USD","LU2242644610.SGD","LU1969619763.USD","LU0320764599.SGD","BK4581","LU2495084118.USD","LU1997244956.HKD","LU2328871848.SGD","VHT","LU2125910500.SGD","BK4585","02359","LU2045819591.USD","LU1979443071.USD","LU1046422090.SGD","LU1997245094.SGD","LU0052750758.USD","LU0708995583.HKD","LU0456842615.SGD","LU1997245177.USD","LU1934453819.USD","BK1576","LU0348766576.USD","BK1141","603259","LU0348767384.USD","XBI","IXJ","BK0216","LU1808992512.USD","BK4588","LABU","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628240719","title":"中信证券:药价形成机制迎来大调整 医疗健康产业政策改革进入密集期","url":"https://stock-news.laohu8.com/highlight/detail?id=2628240719","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628240719?lang=zh_cn&edition=full","pubTime":"2026-04-17 08:12","pubTimestamp":1776384738,"startTime":"0","endTime":"0","summary":"医疗健康产业政策改革进入密集期,建议持续关注政策驱动下的医疗健康产业投资机会。中信证券主要观点如下:事件:4月14日,国务院办公厅印发《关于健全药品价格形成机制的若干意见》,15日国务院政策例行吹风会介绍健全全周期全渠道药品价格形成机制有关情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLV","BK4550","159760","BK1147","BK0276","BK1564","LU1064131003.USD","BK4581","LU1064130708.USD","LU2495084118.USD","BK0012","BK0196","600030","BK0188","LU1997244956.HKD","LU1781817850.SGD","VHT","BK4585","LU1328615791.USD","LU1580142542.USD","LU1997245094.SGD","LU0405327148.USD","LU1794554557.SGD","LU1997245177.USD","BK0028","BK1521","LU0405327494.USD","LU1655091616.SGD","XBI","BK0183","LU1720050803.USD","IXJ","06030","LU2148510915.USD","LU1255011170.USD","LU2289578879.USD","BK1516","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624567801","title":"葛兰旗下中欧医疗健康基金年报来袭!重仓股持续聚焦创新药产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2624567801","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624567801?lang=zh_cn&edition=full","pubTime":"2026-04-01 14:28","pubTimestamp":1775024920,"startTime":"0","endTime":"0","summary":"以其管理规模最大的中欧医疗健康为例,截至2025年年末,该基金的前十大重仓股与隐形重仓股未发生个股的更迭,报告期内持续聚焦创新药械及其产业链、OTC 及消费医疗等核心领域。葛兰表示,2026年继续看好创新药产业链,同时关注医疗器械国产替代与出海、消费医疗的困境反转。从最新披露的年报数据来看,中欧医疗健康的隐形重仓股同样未发生个股的更迭,均为以往持仓中原有的标的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4588","159992","LABU","BK4585","BK1574","BK4581","VHT","XBI","XLV","BK4550","06978","IXJ","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622213879","title":"险企春招忙 AI和医疗健康类人才需求增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2622213879","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622213879?lang=zh_cn&edition=full","pubTime":"2026-03-28 00:08","pubTimestamp":1774627680,"startTime":"0","endTime":"0","summary":"随着“金三银四”招聘季的来临,中国人保、中国平安、新华保险、泰康保险、阳光保险、众安保险等多家险企密集发布2026年春季招聘信息。从岗位需求看,AI(人工智能)、大数据、技术开发等科技类人才以及医疗养老类人才的需求大幅增长。例如,中国平安集团表示,将携手旗下10余家成员公司,面向全球高校开展超3000个校招岗位、1500个实习生岗位的招聘。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603283687541778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["AIPO","BK4585","CHAT","XBI","BK4581","159760","LABU","XLV","AGIX","IXJ","VHT","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622599288","title":"广州:拓展智能机器人在工业制造、家庭服务、医疗健康等领域的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2622599288","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622599288?lang=zh_cn&edition=full","pubTime":"2026-03-26 18:00","pubTimestamp":1774519200,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! (来源:界面新闻)广州市人民政府办公厅印发广州市促进人工智能产业高质量发展实施方案。其中提出,重点推动智能网联汽车、智能无人系统、全屋智能终端、智能可穿戴设备、工业智能终端、脑机接口等智能硬件产品的研发推广,推动车载端侧大模型应用,支持开发家电—中控—传感器协同的AIoT系统。推动具身智能机器人商业化,支持企业自主研发核心零部件,拓展智能机器人在工业制造、家庭服务、医疗健康等领域的应用。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2026-03-26/doc-inhsikaq0160355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4550","LABU","IXJ","BK4588","BK4585","XBI","159760","ROBO","VHT","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622846858","title":"印孚瑟斯拟收购两家美国咨询公司,以加强医疗保健和保险技术产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2622846858","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622846858?lang=zh_cn&edition=full","pubTime":"2026-03-26 10:08","pubTimestamp":1774490887,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0197229882.USD","BK4535","BK4533","XLV","LU2663582299.SGD","LU0536402901.SGD","VHT","LU0531971678.HKD","LU0831103253.SGD","LU0431992006.USD","LU1366334578.USD","LU1508157978.USD","BK4134","BK4588","LU0066902890.USD","LU0791591158.USD","LU2087589342.USD","XBI","LU1323998911.USD","LU0231203729.USD","LU0333810181.USD","LU1102505762.USD","LU2265009873.SGD","IE00B0JY6M65.USD","IE00BYTNYM70.SGD","BK4581","BK4523","LU0898667661.SGD","LU1366334651.USD","LU0791590937.USD","INFY","LU0862451753.SGD","LU1805238398.USD","BK4550","LU0708995666.HKD","LU0287143357.SGD","LU0868486357.SGD","IE00B7N09G41.SGD","LU0348744763.USD","LU1267930656.SGD","LU0890818403.SGD","LU0164881194.USD","LU1804176565.USD","BK4585","IE00B3M56506.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":-0.0252},{"period":"3month","weight":-0.066},{"period":"6month","weight":-0.0428},{"period":"1year","weight":0.1102},{"period":"ytd","weight":-0.0571}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.008213},{"month":2,"riseRate":0.608696,"avgChangeRate":0.001185},{"month":3,"riseRate":0.521739,"avgChangeRate":0.002895},{"month":4,"riseRate":0.608696,"avgChangeRate":0.010267},{"month":5,"riseRate":0.652174,"avgChangeRate":0.005127},{"month":6,"riseRate":0.681818,"avgChangeRate":0.008198},{"month":7,"riseRate":0.727273,"avgChangeRate":0.019444},{"month":8,"riseRate":0.590909,"avgChangeRate":0.005271},{"month":9,"riseRate":0.409091,"avgChangeRate":-0.004416},{"month":10,"riseRate":0.5,"avgChangeRate":-0.000221},{"month":11,"riseRate":0.818182,"avgChangeRate":0.026667},{"month":12,"riseRate":0.545455,"avgChangeRate":0.003563}],"exchange":"ARCA","name":"Vanguard Health Care ETF","nameEN":"Vanguard Health Care ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vanguard Health Care ETF(VHT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vanguard Health Care ETF(VHT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vanguard Health Care ETF,VHT,Vanguard Health Care ETF股票,Vanguard Health Care ETF股票老虎,Vanguard Health Care ETF股票老虎国际,Vanguard Health Care ETF行情,Vanguard Health Care ETF股票行情,Vanguard Health Care ETF股价,Vanguard Health Care ETF股市,Vanguard Health Care ETF股票价格,Vanguard Health Care ETF股票交易,Vanguard Health Care ETF股票购买,Vanguard Health Care ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vanguard Health Care ETF(VHT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vanguard Health Care ETF(VHT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}